Literature DB >> 22605871

Tumefactive demyelination associated with systemic lupus erythematosus.

Rajesh Verma1, Kamal Arya.   

Abstract

Systemic lupus erythematosus (SLE) is a chronic inflammatory multi-system disease characterised by varied clinical manifestation and immunological abnormalities. The clinical presentation of the disorder has wide spectra, from an asymptomatic presentation to a severe life-threatening disease affecting several organs. The sole manifestation of lupus erythematosus could be neurological syndrome, where diagnosis of SLE is difficult to establish. The authors intended to report a young female, who initially developed left-sided hemiparesis due to tumefactive demyelination, later on diagnosed as case of SLE. The association of tumefactive demyelination and SLE has not been previously reported in the literature.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22605871      PMCID: PMC3369371          DOI: 10.1136/bcr.02.2012.5743

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  12 in total

1.  Neuromyelitis optica (Devic's syndrome) as first manifestation of systemic lupus erythematosus.

Authors:  C Jacobi; K Stingele; R Kretz; M Hartmann; B Storch-Hagenlocher; A Breitbart; B Wildemann
Journal:  Lupus       Date:  2006       Impact factor: 2.911

2.  Case Series: tumefactive demyelinating lesions: a diagnostic challenge.

Authors:  Aria Fallah; Sarfaraz Banglawala; Shanil Ebrahim; John E Paulseth; Neilank K Jha
Journal:  Can J Surg       Date:  2010-02       Impact factor: 2.089

Review 3.  The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes.

Authors: 
Journal:  Arthritis Rheum       Date:  1999-04

Review 4.  Tumefactive demyelinating lesions.

Authors:  A P Dagher; J Smirniotopoulos
Journal:  Neuroradiology       Date:  1996-08       Impact factor: 2.804

Review 5.  Neuropsychiatric lupus.

Authors:  W J McCune; J Golbus
Journal:  Rheum Dis Clin North Am       Date:  1988-04       Impact factor: 2.670

6.  Open-ring imaging sign: highly specific for atypical brain demyelination.

Authors:  J C Masdeu; C Quinto; C Olivera; M Tenner; D Leslie; P Visintainer
Journal:  Neurology       Date:  2000-04-11       Impact factor: 9.910

7.  Cerebral MRI abnormalities and their association with neuropsychiatric manifestations in SLE: a population-based study.

Authors:  H Ainiala; P Dastidar; J Loukkola; T Lehtimäki; M Korpela; J Peltola; A Hietaharju
Journal:  Scand J Rheumatol       Date:  2005 Sep-Oct       Impact factor: 3.641

8.  Stroke of the substance nigra and parkinsonism as first manifestation of systemic lupus erythematosus.

Authors:  San-Juan Orta Daniel; Rodríguez-Ortiz Ulises
Journal:  Parkinsonism Relat Disord       Date:  2008-05-02       Impact factor: 4.891

9.  Cognitive dysfunction in systemic lupus erythematosus: prevalence and correlates.

Authors:  J Olazarán; J López-Longo; I Cruz; A Bittini; L Carreño
Journal:  Eur Neurol       Date:  2009-04-30       Impact factor: 1.710

10.  Homonymous hemianopsia as the leading symptom of a tumor like demyelinating lesion: a case report.

Authors:  Maria Eleptheria Evangelopoulos; Dimitrios Stergios Evangelopoulos; Costas Potagas; Costantinos Sfagos
Journal:  Cases J       Date:  2009-12-21
View more
  1 in total

1.  Clinical and imaging correlation in patients with pathologically confirmed tumefactive demyelinating lesions.

Authors:  Matthew A Tremblay; Javier E Villanueva-Meyer; Soonmee Cha; Tarik Tihan; Jeffrey M Gelfand
Journal:  J Neurol Sci       Date:  2017-08-10       Impact factor: 3.181

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.